BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32210395)

  • 1. Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition.
    Jin JH; Huang HH; Zhou MJ; Li J; Hu W; Huang L; Xu Z; Tu B; Yang G; Shi M; Jiao YM; Fan X; Song JW; Zhang JY; Zhang C; Wang FS
    Cell Mol Immunol; 2020 Dec; 17(12):1257-1265. PubMed ID: 32210395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV-1-Infected Individuals on Antiretroviral Therapy.
    Hu W; Li YJ; Zhen C; Wang YY; Huang HH; Zou J; Zheng YQ; Huang GC; Meng SR; Jin JH; Li J; Zhou MJ; Fu YL; Zhang P; Li XY; Yang T; Wang XW; Yang XH; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Huang L; Qin YQ; Wu FY; Shi M; Wang FS; Zhang C
    Front Immunol; 2022; 13():897569. PubMed ID: 35720272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
    Pinzone MR; Graf E; Lynch L; McLaughlin B; Hecht FM; Connors M; Migueles SA; Hwang WT; Nunnari G; O'Doherty U
    J Virol; 2016 Dec; 90(23):10436-10445. PubMed ID: 27630237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CD8 T cells in controlling HIV beyond the antigen-specific face.
    Zhang C; Hu W; Jin JH; Zhou MJ; Song JW; Deng JN; Huang L; Wang SY; Wang FS
    HIV Med; 2020 Dec; 21(11):692-700. PubMed ID: 33369032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure.
    Goonetilleke N; Clutton G; Swanstrom R; Joseph SB
    Front Immunol; 2019; 10():1966. PubMed ID: 31507594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
    Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
    J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing CD8
    Warren JA; Clutton G; Goonetilleke N
    Front Immunol; 2019; 10():291. PubMed ID: 30863403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
    McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
    Huang SH; Ren Y; Thomas AS; Chan D; Mueller S; Ward AR; Patel S; Bollard CM; Cruz CR; Karandish S; Truong R; Macedo AB; Bosque A; Kovacs C; Benko E; Piechocka-Trocha A; Wong H; Jeng E; Nixon DF; Ho YC; Siliciano RF; Walker BD; Jones RB
    J Clin Invest; 2018 Feb; 128(2):876-889. PubMed ID: 29355843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of CD8+ T cell effector diversity during HIV-1 infection with discordant normalization in effective antiretroviral therapy.
    Onlamoon N; Sukapirom K; Polsrila K; Ammaranond P; Pattanapanyasat K
    Cytometry B Clin Cytom; 2012 Jan; 82(1):35-42. PubMed ID: 21915993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed differentiation of potent effector CD8
    Takata H; Buranapraditkun S; Kessing C; Fletcher JL; Muir R; Tardif V; Cartwright P; Vandergeeten C; Bakeman W; Nichols CN; Pinyakorn S; Hansasuta P; Kroon E; Chalermchai T; O'Connell R; Kim J; Phanuphak N; Robb ML; Michael NL; Chomont N; Haddad EK; Ananworanich J; Trautmann L;
    Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation.
    Van de Wijer L; van der Heijden WA; Ter Horst R; Jaeger M; Trypsteen W; Rutsaert S; van Cranenbroek B; van Rijssen E; Joosten I; Joosten L; Vandekerckhove L; Schoofs T; van Lunzen J; Netea MG; Koenen HJPM; van der Ven AJAM; de Mast Q
    Front Immunol; 2021; 12():661990. PubMed ID: 33953724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
    Sevilya Z; Chorin E; Gal-Garber O; Zelinger E; Turner D; Avidor B; Berke G; Hassin D
    Front Immunol; 2018; 9():2068. PubMed ID: 30254642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
    Trabattoni D; Piconi S; Biasin M; Rizzardini G; Migliorino M; Seminari E; Boasso A; Piacentini L; Villa ML; Maserati R; Clerici M
    AIDS; 2004 Apr; 18(6):859-69. PubMed ID: 15060433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.